Correlation Between Agios Pharm and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Edgewise Therapeutics, you can compare the effects of market volatilities on Agios Pharm and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Edgewise Therapeutics.
Diversification Opportunities for Agios Pharm and Edgewise Therapeutics
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Agios and Edgewise is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Agios Pharm i.e., Agios Pharm and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Agios Pharm and Edgewise Therapeutics
Given the investment horizon of 90 days Agios Pharm is expected to generate 0.7 times more return on investment than Edgewise Therapeutics. However, Agios Pharm is 1.43 times less risky than Edgewise Therapeutics. It trades about -0.18 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about -0.2 per unit of risk. If you would invest 3,581 in Agios Pharm on October 20, 2024 and sell it today you would lose (339.00) from holding Agios Pharm or give up 9.47% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agios Pharm vs. Edgewise Therapeutics
Performance |
| Timeline |
| Agios Pharm |
| Edgewise Therapeutics |
Agios Pharm and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agios Pharm and Edgewise Therapeutics
The main advantage of trading using opposite Agios Pharm and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |